The study ‘Migraine comorbidity and phenotypic disease networks in occupational health care’ was presented in the 19th Congress of the International Headache Society in Dublin, Ireland (5-8 September, 2019). The objective of this new RWE study was to further elucidate the migraine burden by examining the ICD-10 coded phenotypic diseasomes for migraine patients. This study was conducted together with Novartis and Terveystalo. You can access the abstract from the link below.
Abstract of Migraine comorbidity and phenotypic disease networks in occupational health care
Migraine comorbidity and phenotypic disease networks in occupational health care. Korolainen M A, Kurki S, Tuominen S, Toppila I, Lassenius M I, Santaholma J, Purmonen T, Nissilä M. 19th Congress of the International Headache Society, Sep 7-8, 2019; Dublin, Ireland.
My list of publications includes over 20 peer-reviewed scientific articles. One of them is a special one because the Finnish Current Care Guidelines mention it for heart failure. This blog discusses the impact of research by Medaffcon on treatment practices.
A study published in January 2024 in the Scandinavian Journal of Gastroenterology has revealed that the treatment of adults with Short Bowel Syndrome (SBS-IF) clearly has significant room for improvement. Patients require extensive amounts of healthcare services, and their mortality rate is elevated.
Our latest multiple myeloma publication describes how complex multiple myeloma treatment patterns were assembled from data available in the Helsinki University Hospital data lake, Finland, how the treatments have changed in 2013–2019, and what the estimated treatment costs are in multiple myeloma.The study published online in October 2023 was carried out by the experts at Medaffcon Oy, Sanofi Oy, and Helsinki University Hospital, Finland.